chemotherapeutics

Related by string. chemotherapeutic * * radioactive isotopes chemotherapeutics . chemotherapeutic agents carboplatin . RH1 targeted chemotherapeutic agent . conventional chemotherapeutic agents . chemotherapeutic agent doxorubicin . oral chemotherapeutic agent . Alchemix chemotherapeutic agent . small molecule chemotherapeutic . chemotherapeutic agents *

Related by context. All words. (Click for frequent words.) 77 chemotherapeutic agents 75 anticancer agents 73 proteasome inhibitors 73 chemotherapeutic drugs 72 anticancer drugs 72 chemotherapeutic 71 chemotherapeutic drug 71 cytotoxic agents 71 chemotherapies 70 cytotoxic 70 taxanes 69 MEK inhibitors 68 nucleoside analogs 68 peptide antigens 68 doxorubicin 67 idarubicin 67 pegfilgrastim 67 kinase inhibitors 67 NNRTIs 67 anticancer therapies 67 Doxorubicin 67 PARP inhibitors 67 molecularly targeted 67 chemotherapeutic agent 67 tyrosine kinase inhibitor 66 antisense oligonucleotides 66 tyrosine kinase inhibitors 66 chemotherapeutic regimens 66 SERMs 65 anticancer agent 65 interferons 65 imatinib Gleevec 65 mTOR inhibitors 65 novel peptide 65 EGFR inhibitors 65 vinca alkaloids 65 anticancer therapy 65 mAbs 65 direct thrombin inhibitors 65 trans retinoic acid ATRA 65 cytotoxic chemotherapy 65 anti angiogenic agents 65 nucleoside analogues 65 Hsp# inhibitors 65 multitargeted 64 vascular disrupting agents 64 monoclonal antibody therapies 64 nucleosides 64 vorinostat 64 siRNA therapeutics 64 proteasome inhibitor 64 therapies 64 selective inhibition 64 taxane chemotherapy 64 lentiviral vectors 64 camptothecin 64 protease inhibitors 64 echinocandin 64 VEGF inhibitors 64 GRN#L 64 taxol 64 EGFR tyrosine kinase inhibitors 64 therapeutic regimens 64 DACH platinum 63 cilengitide 63 CBLC# 63 immune modulators 63 ENMD # 63 Symadex 63 CD# antibody [001] 63 vinca alkaloid 63 Cisplatin 63 etoposide 63 xenograft models 63 taxane 63 HSP# inhibitor 63 small molecule inhibitors 63 microtubule inhibitor 63 cytostatic 63 IFN beta 63 IFN alpha 63 interferon IFN 63 erlotinib Tarceva ® 63 OMP #M# 63 immunomodulatory 63 humanized monoclonal antibodies 63 LNP formulations 63 cyclosporin 63 Gleevec resistant 63 liposomal 63 cytotoxics 63 paclitaxel Taxol 63 immunomodulators 63 busulfan 63 Xanafide 63 calcineurin inhibitors 63 docetaxel Taxotere 63 Monoclonal antibodies 63 aminoglycosides 63 enzyme inhibitors 63 protein kinase inhibitor 63 L asparaginase 63 immunosuppressive agents 63 photosensitizer 63 bevacizumab Avastin 63 GAP #B# 63 Gefitinib 62 proteins peptides 62 TNFa 62 nanomolar 62 Interferon alpha 62 integrin receptors 62 sorafenib Nexavar 62 immunotoxins 62 angiogenesis inhibitor 62 TKIs 62 stable nucleic acid 62 Etoposide 62 Nanobodies 62 Azedra 62 DFMO 62 DsiRNA 62 HuLuc# 62 Mitoxantrone 62 gemcitabine Gemzar 62 amphotericin B 62 p# inhibitors 62 cisplatin 62 alkylating agent 62 endothelin receptor antagonists 62 Raltegravir 62 chemotherapeutic treatments 62 5 FU 62 lapatinib Tykerb 62 HCV protease inhibitors 62 preclinically 62 arsenic trioxide 62 Seliciclib 62 oncolytic 62 bevacizumab Avastin ® 62 histone deacetylase HDAC inhibitors 62 echinocandins 62 imatinib Gleevec ® 62 Vidofludimus 62 JAK2 inhibitors 62 histone deacetylase inhibitors 62 dexamethasone Decadron 62 mycophenolate mofetil 62 ESBA# 62 daunorubicin 62 IAP inhibitor 62 alpha interferon 62 cancer immunotherapies 62 Bortezomib 62 cytotoxicity 62 apoptotic pathway 62 liposomal formulation 62 CXCR4 receptor 62 IAP inhibitors 62 macrolide antibiotics 62 SARMs 62 rHuPH# 62 antiviral therapies 62 Protease inhibitors 62 XmAb# 61 antibody fragment 61 immunotherapies 61 chemotherapy regimens 61 LY# [003] 61 pertuzumab 61 cetuximab Erbitux ® 61 histone deacetylase inhibitor 61 dasatinib Sprycel 61 PARP inhibitor 61 microwave hyperthermia 61 antimetabolite 61 Dasatinib 61 Panzem R NCD 61 Irinotecan 61 humanized antibodies 61 kinase inhibition 61 bleomycin 61 azacytidine 61 deacetylase inhibitors 61 tumor antigens 61 Tarvacin 61 antidiabetic drugs 61 anti mitotic 61 nucleoside analogue 61 pegylated interferons 61 alkylating agents 61 vincristine 61 drug zotarolimus 61 beta lactam antibiotics 61 erlotinib Tarceva 61 viral vectors 61 UsiRNAs 61 leucovorin 61 anti angiogenic agent 61 Nanobody ® 61 liposomal doxorubicin 61 orally bioavailable 61 fusion proteins 61 cytotoxic compounds 61 PI3K inhibitor 61 marketed EGFR 61 trastuzumab Herceptin 61 EGF receptor 61 immunomodulator 61 relapsed ovarian cancer 61 Erlotinib 61 selective inhibitors 61 cisplatin chemotherapy 61 selective kinase inhibitor 61 macrolides 61 Th2 cytokines 61 topotecan 61 Preclinical studies suggest 61 antifolates 61 TACE 61 biologic therapies 61 tyrosine kinase inhibitors TKIs 61 Pertuzumab 61 receptor tyrosine kinase inhibitor 61 VDAs 61 tubulin binding 61 gamma secretase inhibitors 61 RNAi compounds 61 cediranib 61 anticancer treatments 61 orally dosed 61 cleavable linker 61 cephalosporin antibiotics 61 Smac mimetics 61 anti angiogenic 61 JAK inhibitors 61 LHRH antagonists 61 depsipeptide 61 Aurora kinase 61 hormonal therapies 61 paclitaxel 61 antisense compounds 61 iRGD 61 anti CD3 61 Taxol ® 61 interferon lambda 61 nanomedicines 60 amphotericin 60 inhibitor RG# 60 Squalamine 60 Epothilones 60 gemcitabine cisplatin 60 antitumor 60 ansamycin 60 immunosuppressive therapies 60 rifamycins 60 nifurtimox 60 molecular biomarkers 60 aminoglycoside 60 EGFr 60 topoisomerase 60 TNF alpha antagonist 60 Sym# 60 polymerase inhibitors 60 lipid nanoparticles 60 nanoparticle formulation 60 metaglidasen 60 nucleoside analog 60 nucleoside 60 beta lactams 60 amikacin 60 AMPK activators 60 vinorelbine 60 decitabine 60 antifolate 60 CA4P 60 Pemetrexed 60 HDAC inhibitors 60 anticancer 60 cationic lipid 60 lentiviral vector 60 antisense oligonucleotide 60 cytarabine 60 Hsp# inhibition 60 Tumor Necrosis Factor 60 HGS ETR1 60 prostacyclins 60 gefitinib Iressa 60 bortezomib 60 intravenously administered 60 preclinical xenograft models 60 humanized antibody 60 CYT# potent vascular disrupting 60 M2 subunit 60 trabectedin 60 beta lactam 60 immunosuppressive 60 intravesical instillation 60 ErbB3 HER3 60 anti CD# antibodies 60 fulvestrant 60 virus AAV 60 adenoviral 60 AKT inhibitor 60 interferon 60 cidofovir 60 CD# antibodies 60 HIV protease inhibitors 60 immune modulating 60 EGFR antibodies 60 TLR agonists 60 NEUGENE 60 colony stimulating factors 60 Vandetanib 60 lipid lowering therapies 60 insulin sensitizers 60 Trastuzumab 60 PEGylated 60 bicalutamide 60 CCX# 60 antithrombotic 60 endocrine therapies 60 antineoplastic 60 Src inhibitors 60 cancer therapeutics 60 HGS# 60 antisense drugs 60 antitumor activity 60 VAPRISOL 60 administered systemically 60 immune stimulatory 60 immunosuppressives 60 PI3K inhibitors 60 active moiety 60 SERCA2a 60 immunotherapeutic agent 60 docetaxel Taxotere ® 60 5FU 60 Cyclosert 60 OncoVEX GM CSF 60 Bleomycin 60 EphA2 60 Cremophor 60 5 HT3 receptor 60 intradermal injection 60 TRV# [001] 60 CLL cells 60 antiangiogenic 60 ISF# 60 DHFR 60 tigecycline 60 Orally administered 60 antiangiogenic agents 60 iron chelators 60 alkylating 60 anti angiogenic drugs 60 Aliskiren 60 tegafur 60 siRNA 60 endostatin 60 DiLA2 60 pegylated 60 cytotoxic therapies 60 indibulin 60 pentamidine 60 CYP#A# inhibitors 60 sulindac 60 ganetespib 60 beta interferons 60 YONDELIS 60 siRNA therapeutic 59 virotherapy 59 TKI therapy 59 bortezomib Velcade 59 oncolytic virus 59 monoclonal antibodies 59 bifunctional 59 Paraplatin ® 59 antimitotic 59 MMP inhibitors 59 intravesical 59 SIR Spheres 59 photodynamic therapy 59 quinolone 59 effector function 59 Nanobodies ® 59 flavopiridol 59 Taxanes 59 neuraminidase inhibitors 59 REOLYSIN ® 59 Gemcitabine 59 erythropoietic 59 convenient dosing regimens 59 pan HDAC inhibitor 59 potent anticancer 59 pharmacokinetic interactions 59 liposomes 59 proteasome inhibitor bortezomib 59 immunotherapeutics 59 glioma cells 59 Cyclosporine 59 topical formulations 59 vitamin D analogs 59 CCR2 59 prodrugs 59 antitumoral 59 isoproterenol 59 antiproliferative 59 Vidaza ® 59 HDAC inhibition 59 nucleoside reverse transcriptase inhibitor 59 CD# monoclonal antibody 59 monoclonals 59 Fludara 59 small molecule tyrosine 59 trastuzumab Herceptin ® 59 sodium glucose cotransporter 59 Hycamtin 59 Nanobody 59 HER2 receptor 59 radiolabeled antibodies 59 hedgehog pathway 59 immunotherapy 59 chemoresistance 59 antiemetics 59 epithelial tumors 59 TLR9 agonist 59 antihypertensive agents 59 biologic therapeutics 59 GPIIb IIIa 59 intravenous bisphosphonates 59 therapeutic proteins 59 NRTIs 59 uric acid lowering 59 immunosuppressive regimens 59 Tyrima 59 T#I mutant 59 nucleotide analogues 59 transdermally 59 INT# [002] 59 CDDO Im 59 delta isoform 59 imatinib 59 KL4 surfactant 59 Novartis Gleevec 59 daptomycin 59 Interferon alfa 59 antagomirs 59 Zolinza 59 docetaxel chemotherapy 59 indinavir 59 oral prodrug 59 azole 59 small interfering RNA 59 MGd 59 synthetic peptides 59 A3 adenosine receptor 59 act synergistically 59 anthracyclines 59 superficial bladder cancer 59 idraparinux 59 immune modulatory 59 sd rxRNA 59 Anticalins 59 photosensitizers 59 FK# 59 ceftriaxone 59 Fludara ® 59 Oxaliplatin 59 AEG# 59 anti proliferative 59 obatoclax 59 Temsirolimus 59 Amplimexon 59 Herceptin trastuzumab 59 exon skipping 59 standard chemotherapy regimens 59 bendamustine 59 Dapagliflozin 59 BAY #-# 59 solid tumors 59 CYC# 59 HDACi 59 lenalidomide dexamethasone 59 siRNA binds 59 microtubule targeting 59 calcitriol 59 xanthine oxidase inhibitor 59 Bevacizumab 59 Pazopanib 59 beta adrenergic 59 siRNA molecules 59 small molecule defensin 59 dacarbazine 59 CCL# 59 small molecule activators 59 therapeutic monoclonal antibody 59 Litx 59 conventional chemotherapies 59 Lisofylline 59 Temozolomide 59 pharmacokinetic properties 59 potent inhibitors 59 somatostatin analogue 59 talabostat 59 immunotoxin 59 lipid particles 59 vaccine adjuvant 59 VEGFb 59 affinity ligands 59 Imprime PGG 59 BCR ABL inhibitors 59 epirubicin 59 Xencor XmAb 59 amrubicin 59 kinase inhibitor 59 bexarotene 59 Omacetaxine 59 endoxifen 59 imetelstat 59 calcitonin 59 triphosphate 59 inhibitory effects 59 HSP# inhibitors 59 transfection reagents 59 myeloproliferative disorders 59 plasma proteins 59 panobinostat 59 viral vector 59 ligand TRAIL 59 alefacept 58 synthetic peptide 58 VEGF receptor 58 azoles 58 antisense drug 58 letrozole Femara 58 Anticalins ® 58 azacitidine 58 gastrointestinal stromal tumors GIST 58 Paclitaxel 58 hematological cancers 58 EZN 58 IFNs 58 anionic backbone 58 thrombopoietin 58 Omacetaxine mepesuccinate 58 TLR8 58 JAK#/JAK# 58 cisplatin carboplatin 58 AMN# [001] 58 anti tubercular 58 enveloped viruses 58 paclitaxel Taxol ® 58 NF kappaB activation 58 Combination therapy 58 resolvin 58 non nucleoside 58 #HT#A 58 radiolabeled TM# 58 radionuclide therapy 58 oncoproteins 58 synthetic analogues 58 siRNA delivery 58 multi kinase inhibitor 58 gamma secretase inhibitor 58 albumin bound paclitaxel 58 Imatinib 58 inhibiting tumor 58 siRNA compounds 58 proliferative disorders 58 TriRima 58 multikinase inhibitor 58 vascular disrupting agent 58 Voreloxin 58 clavulanate 58 doxorubicin HCl 58 PXD# 58 granisetron 58 rifamycin 58 trans retinoic acid 58 effector functions 58 histone deacetylase HDAC inhibitor 58 visilizumab 58 ixabepilone 58 LHRH agonist 58 anti EGFR antibody 58 adipiplon 58 Neulasta ® 58 Factor VIIa 58 thalidomide Thalomid 58 prostanoid 58 SGLT2 inhibitors 58 fibrinolytic 58 dasatinib 58 myelofibrosis polycythemia vera 58 mecamylamine 58 PSMA ADC 58 antiangiogenesis 58 PKC# 58 dasatinib Sprycel ® 58 NXL# 58 OXi# 58 Trabectedin 58 taxane therapy 58 Taxotere chemotherapy 58 LHRH agonists 58 immunosuppressant 58 cyclophosphamide 58 immunosuppressive drugs 58 signal transduction inhibitor 58 vincristine sulfate 58 Anticalins R 58 anti leukemic 58 RNA antagonist 58 octreotide 58 DAVANAT 58 neurotrophic factors 58 intracellular uptake 58 HER3 58 Vincristine 58 chemically modified siRNA 58 nucleotide analogs 58 heterologous 58 itraconazole 58 HDAC6 58 polyketides 58 DMARDS 58 rituximab Rituxan 58 beta lactam antibiotic 58 caspofungin 58 chemopreventive agents 58 Carfilzomib 58 monoclonal 58 metastatic colorectal 58 targeting CD# 58 oxidative stress inducer 58 Zysolin TM 58 Nilotinib 58 ganciclovir 58 NovaBay Aganocide compounds 58 tumor subtypes 58 fluoropyrimidine 58 vivo potency 58 JAK3 58 AQ4N 58 leflunomide 58 Fulvestrant 58 GRNVAC1 58 DNA intercalator 58 mitochondrial toxicity 58 therapeutically relevant 58 vasodilators 58 docetaxel Taxotere R 58 epothilones 58 ERBB2 58 Zoledronic acid 58 humanized anti 58 radiolabeled monoclonal antibody 58 radiation sensitizer 58 antisense 58 IGF 1R 58 lytic 58 SNALP technology 58 biodistribution 58 CoFactor 58 immunomodulatory therapy 58 BCR ABL 58 Onconase 58 favorable pharmacokinetic profile 58 synthetic retinoid 58 systemically administered 58 glucocorticoid receptor 58 chemotherapeutic regimen 58 radiolabeled 58 signaling cascades 58 neurotoxicity 58 vinblastine 58 interferon beta 58 pyrimethamine 58 NS#/#A protease 58 mRNA antagonists 58 chimeric monoclonal antibody 58 protease inhibitor 58 antimetabolites 58 Liposomal 58 immuno modulatory 58 cyclophilin D 58 immunotherapeutic 58 PPAR gamma agonists 58 proteases 58 TLR8 agonist 58 immunostimulatory 58 glycosylated 58 Gleevec imatinib mesylate 58 glioblastoma cells 58 protein therapeutics 58 GnRH agonists 58 Darinaparsin 58 cytoprotective 58 TLR9 agonists 58 thrombolytic agents 58 TPI ASM8 58 parthenolide 58 recombinant erythropoietin 58 BMS # 58 Doxil ® 58 inhibits protein synthesis 58 tkRNAi technology 58 Nexavar ® 58 selective antagonists 58 gemcitabine 58 heparins 58 cetuximab Erbitux R 58 Cellcept 58 glucocorticoids 58 PLX# 58 temozolomide 58 novel immunomodulatory 58 biphosphonates 58 Taxotere docetaxel 58 nanoviricides 58 nutlin 58 Vidaza azacitidine 58 HepDirect prodrug 58 fluvastatin 58 corticosteroid dexamethasone 58 interferon alpha 58 luteinizing hormone releasing 58 PEP# [003] 58 asparaginase 58 IMP# 58 immunomodulation 58 ISTODAX 58 Sphingomab 58 humanised monoclonal antibody 58 liposome encapsulated 58 thapsigargin 58 #I TM# 58 phosphate S1P 58 Cytoxan 58 nab docetaxel 58 benzimidazole 58 brostallicin 58 poloxamer 58 interferon alfa 58 sPLA2 58 modulators SERMs 58 tumor vasculature 58 HDACs 58 hepatoma 58 JAK2 58 miR #a [002] 58 rxRNA ™ compounds 58 cardiac toxicity 58 renin inhibitors 58 MyVax R 58 palliative radiotherapy 58 PROCHYMAL 58 EGFR TKIs 58 oligonucleotides 58 pharmacologic agents 58 CDK inhibitor 58 milatuzumab 58 humanized monoclonal 58 anti VEGF 58 potent antiproliferative 58 transferrin 58 Interferon beta 58 metastatic renal cell carcinoma 58 integrase inhibitors 58 Lenocta 58 pegylated interferon alfa 58 triphendiol 57 LEP ETU 57 olaparib 57 immunomodulating 57 Debio 57 protein kinase C 57 c MET 57 selectively inhibit 57 hormone LHRH antagonist 57 latanoprost 57 Fibroblast Growth Factor Receptor 57 siRNA molecule 57 belinostat 57 immunological diseases 57 TG# [003] 57 OvaRex ® MAb 57 affinity antibodies 57 hematologic malignancies 57 bispecific antibody 57 Factor Xa inhibitors 57 cisplatin resistant 57 Aplidin 57 angiogenesis inhibition 57 Vinorelbine 57 interferon alfa 2b 57 cephalosporins 57 mapatumumab 57 Allovectin 7 ® 57 VA# [002] 57 Pathway Inhibitor 57 antitumor effect 57 XmAb 57 antifungal drugs 57 PEGPH# 57 Tamibarotene 57 endogenous ligands 57 Aviptadil 57 somatostatin analogues 57 OHR/AVR# 57 DNA gyrase 57 overlapping toxicities 57 Radiation Therapy SIRT 57 epothilone 57 oral antidiabetic 57 tenofovir Viread 57 SCCHN 57 Platinol ® cisplatin 57 tumor specific antigen 57 dextran 57 NEUGENE antisense 57 pDCs 57 SCIg 57 JAK2 inhibitor 57 platelet inhibitor 57 docetaxel 57 rxRNA compounds 57 selective antagonist 57 NF kB pathway 57 skeletal metastases 57 nucleotide analogue 57 nanoparticulate 57 HER2 receptors 57 MDR1 57 therapeutic monoclonal antibodies 57 LT NS# 57 neuroprotectant 57 potent cytotoxic 57 p# inhibitor 57 humanized monoclonal antibody 57 antitumor efficacy 57 IgG1 antibody 57 nanocarriers 57 pro angiogenic 57 radezolid 57 histone deacetylase HDAC 57 delafloxacin 57 Sorafenib 57 anti androgen 57 antiviral compounds 57 partial agonist 57 Abeta# 57 immunosuppressant drug 57 LDL cholesterol lowering 57 chemopreventive agent 57 Lenalidomide 57 Anthracyclines 57 glucagon receptor 57 vascular disrupting 57 anti emetics 57 CHOP chemotherapy 57 NS4A 57 EGFR HER2 57 #beta estradiol 57 MDSCs 57 cytotoxin 57 carboplatin paclitaxel 57 GM CSF 57 antiproliferative effects 57 V#F mutation 57 beta2 adrenergic receptor 57 neuroprotective properties 57 HGS ETR1 mapatumumab 57 ProLindac 57 recombinant antibodies 57 paricalcitol 57 Chemophase 57 biodegradable nanoparticles 57 therapeutics 57 androgen receptor AR 57 oxysterols 57 neuroendocrine cancers 57 pharmacologic 57 Traficet EN 57 Doxil 57 HBV vaccine 57 liposome 57 pyrimidines 57 prodrug 57 sodium stibogluconate 57 conjugate vaccines 57 HQK 57 hTERT 57 ALK inhibitors 57 enzyme inhibitor 57 5 fluorouracil 57 T#I [002] 57 somatostatin receptors 57 JAK1 57 Vidaza R 57 viral antigens 57 nilotinib Tasigna ® 57 dosing frequency 57 optimized siRNA 57 anticancer therapeutics 57 CORT # 57 systemic antifungal 57 pancreatic enzyme replacement 57 immunomodulatory properties 57 Radilex 57 selective HDAC inhibitors 57 Granisetron 57 immunosuppressants 57 pyrazinamide 57 Kamada AAT 57 cyclophosphamide Cytoxan 57 receptor inhibitor 57 MAb 57 polyethylene glycol PEG 57 polymerase inhibitor 57 fluoroquinolone antibiotic 57 MGCD# [001] 57 IgG1 57 Bcr Abl inhibitors 57 retinoid 57 mimetics 57 imatinib mesylate 57 mucosal immunity 57 molecularly targeted therapies 57 BioSilicon 57 ara C 57 sd rxRNAs 57 dose cytarabine 57 TNF alpha inhibitors 57 ONCASPAR 57 evaluating tivozanib 57 nanocarrier 57 prostaglandin synthesis 57 Vorinostat 57 meropenem 57 QuadraSphere 57 TAFA# 57 eflornithine 57 Pegylated Interferon 57 metastatic neuroendocrine tumors 57 lipidoid 57 synthetic siRNA 57 histologies 57 liposomal delivery 57 Taxol paclitaxel 57 preclinical models 57 Talabostat 57 adecatumumab 57 VEGFR2 57 tyrosine kinase inhibitor TKI 57 immunoconjugate 57 OncoVEX 57 RONDEL 57 ubiquinone 57 HDAC inhibitor 57 bryostatin 57 isotypes 57 transgene expression 57 oral proteasome inhibitor 57 renin inhibitor 57 antifungal agents 57 PDE4 inhibitors 57 mda 7 57 antibody fragments 57 thymidylate synthase TS 57 glycolipids 57 Ganciclovir 57 peptidic 57 long acting bronchodilator 57 MNTX 57 triterpenoids 57 temsirolimus 57 soluble receptor 57 EGFR 57 BiTE 57 Panzem 57 Dalbavancin 57 macrolide antibiotic 57 iNOS 57 PDGF receptor 57 antiinflammatory 57 antihypertensive drugs 57 personalized immunotherapy 57 oral antiviral 57 enzastaurin 57 RGB # 57 disease modifying 57 Fludarabine 57 SPC# [001] 57 MAGE A3 ASCI 57 GW# [003] 57 vWF 57 CYP #A#

Back to home page